Salesforce management factors for successful new product launch
暂无分享,去创建一个
Darek Haftor | Natallia Pashkevich | Natallia Pashkevich | D. Haftor | Stefan Fraenkel | Stefan Fraenkel
[1] Erik Brynjolfsson,et al. Complementarity in Organizations , 2012 .
[2] S. Wold,et al. The Collinearity Problem in Linear Regression. The Partial Least Squares (PLS) Approach to Generalized Inverses , 1984 .
[3] J. Guiltinan,et al. Launch Strategy, Launch Tactics, and Demand Outcomes , 1999 .
[4] Nic S. Terblanche. New pharmaceutical product development: Barriers to overcome and opportunities to exploit , 2008 .
[5] Teresa M. Amabile,et al. The Work Preference Inventory: Assessing Intrinsic and Extrinsic Motivational Orientations , 1994 .
[6] Basil Achilladelis,et al. The dynamics of technological innovation: the case of the pharmaceutical industry , 2001 .
[7] David Besanko,et al. Economics of Strategy , 1995 .
[8] Thomas R. Wotruba,et al. How New Product Introductions Affect Sales Management Strategy: The Impact of Type of “Newness” of the New Product , 2003 .
[9] R Bro,et al. Cross-validation of component models: A critical look at current methods , 2008, Analytical and bioanalytical chemistry.
[10] Erik Jan Hultink,et al. Managing diffusion barriers when launching new products , 2010 .
[11] A. Tsui,et al. Configurational Approaches to Organizational Analysis , 1993 .
[12] R. Gibbons,et al. The Handbook of Organizational Economics , 2012 .
[13] George J. Avlonitis,et al. Selling and sales management: An introduction to the special section and recommendations on advancing the sales research agenda , 2010 .
[14] P. Kotler,et al. Principles of Marketing , 1983 .
[15] Ira Horowitz,et al. New-product success in the pharmaceutical industry: how many bites at the cherry? , 2005 .
[16] E. Hultink,et al. The effect of sales force adoption on new product selling performance , 2000 .
[17] E. Hultink,et al. The Impact of Market Orientation, Product Advantage, and Launch Proficiency on New Product Performance and Organizational Performance , 2004 .
[18] K. Atuahene–Gima,et al. Adoption of new products by the sales force: The construct, research propositions, and managerial implications , 1997 .
[19] J. DiMasi,et al. Drug development costs when financial risk is measured using the Fama-French three-factor model. , 2009, Health economics.
[20] Olav M. Kvalheim,et al. Interpretation of latent-variable regression models , 1989 .
[21] Tarja Rajalahti,et al. Discriminating variable test and selectivity ratio plot: quantitative tools for interpretation and variable (biomarker) selection in complex spectral or chromatographic profiles. , 2009, Analytical chemistry.
[22] O. Kvalheim,et al. Multivariate data analysis in pharmaceutics: a tutorial review. , 2011, International journal of pharmaceutics.
[23] Robert G. Cooper,et al. Benchmarking new product performance:: Results of the best practices study , 1998 .
[24] R. Oliver,et al. Behavior- and Outcome-Based Sales Control Systems: Evidence and Consequences of Pure-Form and Hybrid Governance , 2013 .
[25] A. Richter,et al. The Whole Is More Than the Sum of Its Parts— Or Is It? A Review of the Empirical Literature on Complementarities in Organizations , 2010 .
[26] D. J. Roberts,et al. The modern firm , 2004 .
[27] Roger J. Calantone,et al. Clustering product launches by price and launch strategy , 2007 .
[28] A. Griffin,et al. PDMA Success Measurement Project: Recommended Measures for Product Development Success and Failure , 1996 .
[29] C. Benedetto. Identifying the key success factors in new product launch , 1999 .
[30] Paul Milgrom,et al. Complementarities and fit strategy, structure, and organizational change in manufacturing , 1995 .
[31] S. W. Hartley,et al. Sales Force Activities and Marketing Strategies in Industrial Firms: Relationships and Implications , 2001 .
[32] Abbie Griffin,et al. Industrial New Product Launch Strategies and Product Development Performance , 1997 .